Corona Remedies Limited (CORONA)

Volume: 752Avg Vol 1W: 2,502Avg Vol 1M: 14,96952W Range:₹1,336.6₹2,100.7

₹1,792.4▲ 2.39%

Key Ratios

Market Cap₹10,571 Cr

Current Price₹1,792.4

Previous Close₹1,750.6

High / Low (52w)₹2,100.7 / ₹1,336.6

Volume752

Avg Vol (1W)2,502

Avg Vol (1M)14,969

Stock P/E—

Book Value₹122.12

Dividend Yield0.58%

ROE24.79%

ROA15.36%

Revenue (TTM)—

Revenue Growth17.93%

Profit Margin13.19%

Total Debt₹16 Cr

Shares Outstanding6 Cr

Face Value₹10

EPS (TTM)₹7.41

P/B14.38

Debt / Equity0.22

50 DMA₹1,719.33

200 DMA₹1,612.23

Day change+2.39%

Price Chart

₹1,792.4▲ 24.61% · 1Y

2025-12-15

2026-06-16

20-day avg volume: 9K shares

Pros

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	₹353 Cr	₹342 Cr	₹361 Cr	₹347 Cr	₹294 Cr	₹298 Cr	₹314 Cr
EBITDA	₹56 Cr	₹76 Cr	₹72 Cr	₹63 Cr	₹46 Cr	₹60 Cr	₹60 Cr
Net Profit	₹45 Cr	₹41 Cr	₹52 Cr	₹46 Cr	₹32 Cr	₹45 Cr	₹43 Cr
EPS	7.41	6.75	8.55	7.55	5.16	7.35	7.03

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2020
Revenue	₹1,202 Cr	₹1,021 Cr	₹891 Cr	₹624 Cr	₹605 Cr
EBITDA	₹209 Cr	₹133 Cr	₹115 Cr	₹4 Cr	₹79 Cr
Net Profit	₹149 Cr	₹91 Cr	₹85 Cr	₹0 Cr	₹59 Cr
EPS	24.43	14.8	14.57	-0.08	106.83

Balance Sheet

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2020
Total Assets	₹930 Cr	₹831 Cr	₹595 Cr	₹511 Cr	₹396 Cr
Total Liabilities	₹324 Cr	₹350 Cr	₹187 Cr	₹190 Cr	₹127 Cr
Equity	₹606 Cr	₹480 Cr	₹409 Cr	₹321 Cr	₹269 Cr
Total Debt	₹16 Cr	₹67 Cr	₹0 Cr	₹17 Cr	₹18 Cr

Cash Flow

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Operating	₹234 Cr	₹175 Cr	₹129 Cr	₹99 Cr
Investing	₹-84 Cr	₹-267 Cr	₹-50 Cr	₹-66 Cr
Financing	₹-107 Cr	₹99 Cr	₹-45 Cr	₹-30 Cr
Free Cash Flow	₹234 Cr	₹175 Cr	₹129 Cr	₹99 Cr

Shareholding

Promoter 69% Institutions 9.26% Public 21.74%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search